• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多排螺旋 CT 特征对预测胰腺神经内分泌肿瘤患者总生存结局的预后价值。

The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.

机构信息

Department of Radiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Radiology, Zhejiang Prison Center Hospital (Zhejiang Youth Hospital), Hangzhou, China.

Department of Radiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Eur J Radiol. 2020 Mar;124:108847. doi: 10.1016/j.ejrad.2020.108847. Epub 2020 Jan 23.

DOI:10.1016/j.ejrad.2020.108847
PMID:31991300
Abstract

PURPOSE

To assess the prognostic value of multidetector CT in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors (PNETs).

METHOD

Seventy-one patients pathologically diagnosed with PNETs were retrospectively included. The clinical and imaging information was evaluated by two radiologists. The difference between well-differentiated and poorly differentiated PNETs was analyzed. Cox proportional hazards models were created to determine the risk factors for overall survival. Kaplan-Meier survival analyses with log-rank tests were used among different subgroups of patients with PNETs.

RESULTS

In the whole cohort, the median survival was 36 months, and the 5-year survival rate was 84.8 %. Patients with poorly differentiated PNETs were more likely to present with symptoms, abnormal tumor markers, larger diameters, irregular shapes, ill-defined margins, invasion into nearby tissues, liver and lymph node metastases, and lower enhancement ratio than those with well-differentiated PNETs (P < 0.05). In the multivariate analysis, lymph node metastases (hazard ratio: 21.52, P = 0.009) and a portal enhancement ratio less than 1.02 (hazard ratio: 30.89, P = 0.024) were significant factors for overall survival. Overall survival decreased with an ill-defined margin, irregular shape, poor differentiation, grade 3 disease, nonfunctional status, abnormal tumor marker levels, invasion into nearby tissues, lymph node and liver metastases, and lower enhancement ratio (log-rank P < 0.05).

CONCLUSIONS

Poorly differentiated PNETs were more aggressiveness than well-differentiated PNETs. Lymph node metastases and a portal enhancement ratio < 1.02 were independent prognostic factors for worse overall survival outcomes in patients with PNETs.

摘要

目的

评估多排螺旋 CT 对预测胰腺神经内分泌肿瘤(PNETs)患者总生存结局的预后价值。

方法

回顾性纳入 71 例经病理诊断为 PNETs 的患者。由 2 位放射科医生评估临床和影像学资料。分析分化良好和分化差的 PNETs 之间的差异。采用 Cox 比例风险模型确定总生存的危险因素。采用 Kaplan-Meier 生存分析和对数秩检验对不同 PNETs 亚组患者进行分析。

结果

在整个队列中,中位生存时间为 36 个月,5 年生存率为 84.8%。与分化良好的 PNETs 相比,分化差的 PNETs 患者更有可能出现症状、肿瘤标志物异常、肿瘤直径较大、形态不规则、边界不清、侵犯邻近组织、肝和淋巴结转移以及增强比值较低(P<0.05)。多因素分析显示,淋巴结转移(风险比:21.52,P=0.009)和门静脉增强比值<1.02(风险比:30.89,P=0.024)是总生存的显著因素。总体生存随着边界不清、形态不规则、分化差、3 级疾病、无功能状态、肿瘤标志物水平异常、侵犯邻近组织、淋巴结和肝转移以及增强比值较低而降低(对数秩 P<0.05)。

结论

分化差的 PNETs 比分化良好的 PNETs 更具侵袭性。淋巴结转移和门静脉增强比值<1.02 是 PNETs 患者总生存结局较差的独立预后因素。

相似文献

1
The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.多排螺旋 CT 特征对预测胰腺神经内分泌肿瘤患者总生存结局的预后价值。
Eur J Radiol. 2020 Mar;124:108847. doi: 10.1016/j.ejrad.2020.108847. Epub 2020 Jan 23.
2
Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.MDCT 分级 3 胰腺神经内分泌肿瘤:建立诊断模型并与胰腺导管腺癌的生存情况进行比较。
AJR Am J Roentgenol. 2020 Aug;215(2):390-397. doi: 10.2214/AJR.19.21921. Epub 2020 May 20.
3
Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis.胰腺神经内分泌肿瘤:术前磁共振成像特征可预测淋巴结转移。
Abdom Radiol (NY). 2019 Mar;44(3):1000-1009. doi: 10.1007/s00261-018-1863-y.
4
Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.基于增强特征预测胰腺神经内分泌肿瘤的淋巴结转移。
Pancreatology. 2017 Nov-Dec;17(6):956-961. doi: 10.1016/j.pan.2017.08.003. Epub 2017 Aug 19.
5
Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.增强 CT 定量分析在鉴别高分化胰腺神经内分泌肿瘤和低分化神经内分泌癌中的应用。
Eur Radiol. 2022 Dec;32(12):8317-8325. doi: 10.1007/s00330-022-08891-4. Epub 2022 Jun 27.
6
Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.基于新分级分类法的高分化胰腺神经内分泌肿瘤根治性切除术后复发危险因素分析
J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):418-25. doi: 10.1002/jhbp.47. Epub 2013 Oct 20.
7
Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.非富血供胰腺神经内分泌肿瘤:MDCT 成像表现谱及与胰腺导管腺癌的鉴别诊断。
Eur J Radiol. 2019 Jan;110:66-73. doi: 10.1016/j.ejrad.2018.04.006. Epub 2018 Apr 11.
8
Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.动态对比增强计算机断层扫描中含等密度或低密度区域的胰腺神经内分泌肿瘤:影像表现谱及病理分级
Eur J Radiol. 2015 Nov;84(11):2103-9. doi: 10.1016/j.ejrad.2015.08.014. Epub 2015 Aug 22.
9
Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.胰腺实性无功能性内分泌肿瘤:计算机断层扫描与病理学的相关性
HPB (Oxford). 2017 Nov;19(11):986-991. doi: 10.1016/j.hpb.2017.06.013. Epub 2017 Aug 4.
10
Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.应用动态增强 CT 对胰腺神经内分泌癌和高分化神经内分泌肿瘤进行比较。
Eur Radiol. 2020 Sep;30(9):4772-4782. doi: 10.1007/s00330-020-06867-w. Epub 2020 Apr 28.

引用本文的文献

1
Development and validation of a CT-based nomogram to preoperative prediction of pancreatic neuroendocrine tumors (pNETs) grade.基于CT的列线图用于术前预测胰腺神经内分泌肿瘤(pNETs)分级的开发与验证。
Abdom Radiol (NY). 2025 Apr 28. doi: 10.1007/s00261-025-04959-z.
2
A CT-based diagnostic nomogram and survival analysis for differentiating grade 3 pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.基于CT的诊断列线图及生存分析,用于鉴别3级胰腺神经内分泌肿瘤与胰腺导管腺癌。
Front Oncol. 2024 Aug 29;14:1443213. doi: 10.3389/fonc.2024.1443213. eCollection 2024.
3
Surgical resection of double advanced pancreatic neuroendocrine tumors with multiple renal cell carcinoma associated with von Hippel-Lindau disease.
手术切除与 von Hippel-Lindau 病相关的多发性肾细胞癌的双进展性胰腺神经内分泌肿瘤。
Clin J Gastroenterol. 2024 Aug;17(4):697-704. doi: 10.1007/s12328-024-01967-2. Epub 2024 May 2.
4
Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.基于 CT 的影像组学对 1-2 级胰腺神经内分泌肿瘤的预后价值。
Cancer Imaging. 2024 Feb 23;24(1):28. doi: 10.1186/s40644-024-00673-z.
5
Duodenal neuroendocrine neoplasms on enhanced CT: establishing a diagnostic model with duodenal gastrointestinal stromal tumors in the non-ampullary area and analyzing the value of predicting prognosis.增强 CT 下十二指肠神经内分泌肿瘤:建立非壶腹区十二指肠胃肠道间质瘤的诊断模型及预测预后价值分析。
J Cancer Res Clin Oncol. 2023 Nov;149(16):15143-15157. doi: 10.1007/s00432-023-05295-9. Epub 2023 Aug 27.
6
Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.增强 CT 定量分析在鉴别高分化胰腺神经内分泌肿瘤和低分化神经内分泌癌中的应用。
Eur Radiol. 2022 Dec;32(12):8317-8325. doi: 10.1007/s00330-022-08891-4. Epub 2022 Jun 27.
7
Qualitative imaging features of pancreatic neuroendocrine neoplasms predict histopathologic characteristics including tumor grade and patient outcome.胰腺神经内分泌肿瘤的定性成像特征可预测组织病理学特征,包括肿瘤分级和患者预后。
Abdom Radiol (NY). 2022 Dec;47(12):3971-3985. doi: 10.1007/s00261-022-03430-7. Epub 2022 Feb 15.
8
Imaging of Pancreatic Neuroendocrine Neoplasms.胰腺神经内分泌肿瘤的影像学表现。
Int J Environ Res Public Health. 2021 Aug 24;18(17):8895. doi: 10.3390/ijerph18178895.